1. Factors affecting seroreversion by 6 months among healthcare workers in Connecticut. (March 2022) Authors: Althoff, A.; Papasavas, P.; Olugbile, S.; Wu, U.; Roberts, A.L.; O'Sullivan, D.M.; McLaughlin, T.; Mather, J.F.; Steinberg, A.C.; Orlando, R.; Kumar, A. Journal: Journal of hospital infection Issue: Volume 121(2022) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. (April 2017) Authors: d'Arminio Monforte, A.; Andreoni, M.; Angarano, G.; Antinori, A.; Castelli, F.; Cauda, R.; Di Perri, G.; Galli, M.; Iardino, R.; Ippolito, G.; Lazzarin, A.; Perno, C.F.; von Schloesser, F.; Viale, P.; Castagna, A.; Ceccherini-Silberstein, F.; Cozzi-Lepri, A.; Girardi, E.; Lo Caputo, S.; Mussini, C. Journal: Clinical microbiology and infection Issue: Volume 23:Number 4(2017) Page Start: 267.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis. Issue 3 (4th July 2016) Authors: Renna, S.; Orlando, E.; Macaluso, F. S.; Maida, M.; Affronti, M.; Giunta, M.; Sapienza, C.; Rizzuto, G.; Orlando, R.; Dimarco, M.; Cottone, M.; Orlando, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 3(2016) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab. Issue 7 (7th March 2018) Authors: Macaluso, F. S.; Orlando, R.; Renna, S.; Sapienza, C.; Ventimiglia, M.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 7(2018) Page Start: 1040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Measuring benefits at end of life for economic evaluation: measure development and a 'thinkaloud' study. Issue 2 (1st June 2012) Authors: Coast, J.; Sutton, E.; Orlando, R.; Armour, K. Journal: BMJ supportive & palliative care Issue: Volume 2:Issue 2(2012) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.02.3 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). (1st October 2020) Authors: Macaluso, F.S.; Ventimiglia, M.; Fries, W.; Viola, A.; Cappello, M.; Scrivo, B.; Magnano, A.; Pluchino, D.; Camilleri, S.; Garufi, S.; Di Mitri, R.; Mocciaro, F.; Magrì, G.; Ferracane, C.; Citrano, M.; Graziano, F.; Bertolami, C.; Renna, S.; Orlando, R.; Rizzuto, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety. (15th March 2017) Authors: Orlando, A.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, A.; Carroccio, A.; Genova, S.; Calandruccio, G.; Vassallo, R.; Romano, C.; Magazzù, G.; Citrano, M.; Accomando, S. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience. (15th March 2017) Authors: Macaluso, F.S.; Sapienza, C.; Ventimiglia, M.; Renna, S.; Rizzuto, G.; Orlando, R.; Affronti, M.; Orlando, E.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants. (15th March 2017) Authors: Macaluso, F.S.; Maida, M.; Renna, S.; Orlando, E.; Affronti, M.; Sapienza, C.; Dimarco, M.; Orlando, R.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.12.1 SPOSIB SB2 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2. (1st October 2020) Authors: Macaluso, F.S.; Fries, W.; Viola, A.; Centritto, A.; Cappello, M.; Giuffrida, E.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Vinci, E.; Vassallo, R.; Trovatello, A.; Belluardo, N.; Giangreco, E.; Camilleri, S.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Renna, S.; Orlando, R. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗